Audiologists in Yonkers, NY Accepting Medicare

5 Audiologists found. Showing 1 - 5

Shelley Hirsch, M.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 955 Yonkers Ave, Yonkers, NY 10704 Phone: 914-310-3278

Dr. Barbara Anne Tartaglia, AU.D Audiologist Medicare: Accepting Medicare Assignments Practice Location: 984 N Broadway, Suite 400, Yonkers, NY 10701 Phone: 914-963-8588    Fax: 914-963-0253

Carmelina Cerrone, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 984 N Broadway, Suite 400, Yonkers, NY 10701 Phone: 914-963-8588

Mrs. Mary Elizabeth O'sullivan, MA CCCA Audiologist Medicare: Accepting Medicare Assignments Practice Location: 984 N Broadway, Suite400, Yonkers, NY 10701 Phone: 914-963-8588    Fax: 914-963-0253

Dr. Kaitlyn S O'rourke, AU.D, F-AAA, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 622 Yonkers Ave, Unit 2, Yonkers, NY 10704 Phone: 914-968-7555

News Archive

Argos presents positive AGS-003 Phase 2 data for newly diagnosed advanced renal cell carcinoma at ASCO

Argos Therapeutics today announced the presentation of positive interim data from a Phase 2 trial that evaluated the clinical activity, safety and immune response of AGS-003 treatment, given in combination with sunitinib, in patients with newly diagnosed advanced renal cell carcinoma (RCC). The data were discussed June 7 in a poster session at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.

Blog, forthcoming paper examine PEPFAR's 'financial flows'

Noting the release of the Institute of Medicine's PEPFAR evaluation and "our own work-in-progress on PEPFAR's value for money and data management," Victoria Fan, a research fellow at the Center for Global Development (CGD), and Rachel Silverman, a research assistant at CGD, highlight "two focus areas that ... are the subject of a forthcoming CGD policy paper on PEPFAR's financial flows" in a post on CGD's "Global Health Policy" blog.

Drug delivery still has great development potential

Nanocapsules and other containers can transport drugs through a patient's body directly to the origin of the disease and release them there in a controlled manner. Such sophisticated systems are occasionally used in cancer therapy. Because they work very specifically, they have fewer side effects than drugs that are distributed throughout the entire organism.

MEDIAN Technologies receives OSEO 'Innovative Company' accreditation

MEDIAN Technologies, the leading provider of clinical applications for quantitative management of treatment responses in oncology imaging, today announced that it had obtained "Innovative Company" accreditation from OSEO (the French state innovation agency). This accreditation enables innovation-focused French investment funds (Fonds Communs de Placement dans l'Innovation) to invest in MEDIAN Technologies and enjoy a number of fiscal advantages.

FDA clears Fujifilm's Aspire HD breast imaging system

Breast Imaging facilities looking for increased diagnostic confidence in mammography screening can now benefit from the exceptional image quality of the Aspire HD Full Field Digital Mammography (FFDM) system from FUJIFILM Medical Systems U.S.A., Inc. Now FDA 510(k) cleared, the Aspire HD provides image clarity that enables extraordinary detail of potential abnormalities that not only assists in more accurate and reliable diagnoses, but also results in enhanced clinician productivity.

Read more Medical News

› Verified 6 days ago